New Gene Regulatory Proteins Regulating Erythroid Development
调节红细胞发育的新基因调节蛋白
基本信息
- 批准号:8205182
- 负责人:
- 金额:$ 50.03万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2011
- 资助国家:美国
- 起止时间:2011-08-15 至 2016-06-30
- 项目状态:已结题
- 来源:
- 关键词:AffectAnemiaAplastic AnemiaBindingBioinformaticsBiological AssayCFU-ECell Culture TechniquesCell CycleCell ProliferationCell SizeCell divisionCellsCharacteristicsChromatinCollaborationsCoupledDNA-Binding ProteinsDatabasesDevelopmentDevelopmental BiologyDevelopmental ProcessDiamond-Blackfan anemiaDiseaseDown-RegulationElongation FactorEmbryoEnzymesEpigenetic ProcessErythroblastsErythrocytesErythroidErythroid CellsErythropoiesisErythropoietinExportinsFetal LiverFibronectinsGene ExpressionGenerationsGenesGenetic TranscriptionGlycophorinGoalsHDAC2 geneHemoglobinHistonesHumanInstructionKnockout MiceKnowledgeLaboratoriesMeasuresMessenger RNAMolecular ProfilingMusNuclearNuclear ExportPhosphotransferasesPhysical condensationPlayPromoter RegionsProteinsRNA Polymerase IIRoleSideroblastic AnemiaSiteStagingSurfaceTFRC geneThalassemiaTranscriptional RegulationTransferrin ReceptorWithdrawalWorkZebrafishbaseerythroid differentiationgenetic regulatory proteinhistone modificationin vivoknock-downleukemiamRNA Expressionprogenitorpromoterresearch studytranscription factor
项目摘要
PROJECT SUMMARY (See instructions):
Using a combination of second generation mRNA sequencing and bioinformatic approaches we have obtained a complete list of mRNAs expressed at each stage of development from the CFU-E stage to the enucleating erythroblast. We identified 14 genes that are strongly upregulated during this period and that encode transcription factors, chromatin-modifying enzymes, RNA Polymerase II elongation factors, or DNA
binding proteins that have important roles in other developmental processes but whose functions in red cell development have never been explored: Runx1t1, Sertad2, SertadS, Mxd1, Mxd3, Btg2, Med13l, Ncoa7, Calcocol, Asf1b, Dedd2, Bag1, Hdac11, HEXIM1, and EII2. In Aim 1 we will determine which of these 14
proteins plays an important role in erythroid development from the CFU-E stage by systematically knocking down each in purified CFU-E cells and culturing them in the presence of Epo. Broad effects will be assayed by measuring proliferation, induction of CD-71 and Ter-119, nuclear condensation, enucleation, and accumulation of hemoglobin and other marker erythroid- important genes. In collaboration with the Zon laboratory we will knockdown each of these in zebra fish embryos and assess effects on erythropoiesis. In Aim 2, for HDAC2, Hipk-1 and -2, and the new factors that have the most dramatic effects on erythropoiesis when knocked down, we will determine the genes whose expression is directly and indirectly regulated by them, using second generation mRNA sequencing on cultured knockdown mouse progenitors. Finally, in Aim #3 we will determine the global roles of these factors on Polll binding to promoter regions, Polll elongation, and in some cases epigenetic histone modifications As example, using progenitors in which the factors have been knocked down, we will measure by Chip-seq the global distributions of Polll and two histone modifications characteristic of transcriptional elongation. Coupled with bioinformatic analysis we will determine whether control of erythroid- important gene transcription during erythropoiesis by each of these factors works at the level of Polll binding or Polll elongation. These and other studies will create an extensive framework for understanding the epigenetic and transcriptional regulatory networks active in terminal erythropoiesis.
项目摘要(请参阅说明):
使用第二代mRNA测序和生物信息学方法的组合,我们获得了从CFU-E阶段到浓缩的红细胞的每个发育阶段表达的mRNA的完整列表。我们确定了在此期间强烈上调的14个基因,并编码转录因子,染色质修饰酶,RNA聚合酶II伸长因子或DNA
在其他发育过程中具有重要作用但在红细胞发育中起作用的结合蛋白质从未探索过:runx1t1,sertad2,sertads,sertads,mxd1,mxd3,mxd3,btg2,med13l,ncoa7,ncoa7,carcocol,carcocol,carcocol,asf1b,asf1b,deDd2,dedd2,dewd2,hdaC11,hdac11,hexim1,hexim1和eiii2。在AIM 1中,我们将确定这14个
蛋白质在纯化的CFU-E细胞中系统地击倒每种细胞并在EPO存在下培养它们,从而在CFU-E阶段从CFU-E阶段发育起着重要作用。通过测量CD-71和TER-119的增殖,核凝结,摘除以及血红蛋白和其他标志物红细胞促红细胞的积累,可以测定广泛的影响。在与ZON实验室合作的情况下,我们将在斑马鱼胚胎中淘汰每一个,并评估对红细胞生成的影响。在AIM 2中,对于HDAC2,HIPK -1和-2,以及对撞倒红细胞生成的最大作用的新因素,我们将使用第二代MRNA测序对培养的MRNA测序对培养的敲低小鼠祖细胞的直接和间接调节的基因进行确定。最后,在AIM#3中,我们将确定这些因素在对启动子区域,轮询伸长延伸的频率结合中的全球作用,在某些情况下,表观遗传组蛋白修饰为例如,使用偏移量敲低因素的祖细胞,我们将通过Chip-seq进行测量,Chip-Seq的全球polll和两种组蛋白修饰的经转录率的典型均具有转录的特征。再加上生物信息学分析,我们将确定每个因素在红细胞生成过程中对红斑中重要基因转录的控制是否在polll结合或频率伸长的水平上起作用。这些研究和其他研究将创建一个广泛的框架,以理解活跃于终末红霉病的表观遗传和转录调节网络。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Harvey F Lodish其他文献
Harvey F Lodish的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Harvey F Lodish', 18)}}的其他基金
Epo, Integrins and the Control of Erythrpoiesis
Epo、整合素和红细胞生成的控制
- 批准号:
7458640 - 财政年份:2007
- 资助金额:
$ 50.03万 - 项目类别:
Epo, Integrins and the Control of Erythrpoiesis
Epo、整合素和红细胞生成的控制
- 批准号:
7217632 - 财政年份:2006
- 资助金额:
$ 50.03万 - 项目类别:
Adiponectin in Cardiovascular Biology and Pathology
脂联素在心血管生物学和病理学中的作用
- 批准号:
7217666 - 财政年份:2006
- 资助金额:
$ 50.03万 - 项目类别:
Growth factors and engineered stroma for HSC expansion
用于 HSC 扩增的生长因子和工程基质
- 批准号:
6895286 - 财政年份:2004
- 资助金额:
$ 50.03万 - 项目类别:
Growth factors and engineered stroma for hematopoietic stem csll (HSC) expansion
用于造血干 csll (HSC) 扩增的生长因子和工程化基质
- 批准号:
7627338 - 财政年份:2004
- 资助金额:
$ 50.03万 - 项目类别:
Growth factors and engineered stroma for hematopoietic stem csll (HSC) expansion
用于造血干 csll (HSC) 扩增的生长因子和工程化基质
- 批准号:
7847420 - 财政年份:2004
- 资助金额:
$ 50.03万 - 项目类别:
相似国自然基金
BeAn 58058病毒影响cofilin 1功能介导重型再生障碍性贫血患者髓样树突状细胞激活及其机制的研究
- 批准号:82300239
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
BATF高表达对再生障碍性贫血T细胞分化及功能的影响
- 批准号:81600093
- 批准年份:2016
- 资助金额:17.0 万元
- 项目类别:青年科学基金项目
基于SDF-1/CXCR4-PI3K/Akt信号通路研究补肾活血法对再生障碍性贫血骨髓MSCs功能的影响
- 批准号:81373634
- 批准年份:2013
- 资助金额:16.0 万元
- 项目类别:面上项目
IL-27/IL-27R在再生障碍性贫血中的表达及其对免疫和造血的影响
- 批准号:81160071
- 批准年份:2011
- 资助金额:52.0 万元
- 项目类别:地区科学基金项目
细胞免疫异常对骨髓间充质干细胞成脂分化的影响及在再障发病中的作用
- 批准号:81070399
- 批准年份:2010
- 资助金额:34.0 万元
- 项目类别:面上项目
相似海外基金
The role of Rpl5 haploinsufficiency in hematopoietic stem/progenitor cell function in Diamond Blackfan anemia
Rpl5 单倍体不足在 Diamond Blackfan 贫血造血干/祖细胞功能中的作用
- 批准号:
10368461 - 财政年份:2022
- 资助金额:
$ 50.03万 - 项目类别:
Autoimmune responses associated with SARS-CoV-2 infection
与 SARS-CoV-2 感染相关的自身免疫反应
- 批准号:
10611414 - 财政年份:2022
- 资助金额:
$ 50.03万 - 项目类别:
A Phase III Randomized Trial Comparing Unrelated Donor Bone Marrow Transplantation with Immune Suppressive Therapy for Newly Diagnosed Pediatric and Young Adult Patients with Severe Aplastic Anemia
一项针对新诊断患有严重再生障碍性贫血的儿童和年轻成人患者进行非亲缘供体骨髓移植与免疫抑制治疗比较的 III 期随机试验
- 批准号:
10368246 - 财政年份:2022
- 资助金额:
$ 50.03万 - 项目类别:
Eltombopag: Novel Mode of Action on Normal and Aplastic Anemia Hematopoietic Stem Cells
Eltombopag:对正常和再生障碍性贫血造血干细胞的新作用模式
- 批准号:
10676888 - 财政年份:2022
- 资助金额:
$ 50.03万 - 项目类别:
The role of Rpl5 haploinsufficiency in hematopoietic stem/progenitor cell function in Diamond Blackfan anemia
Rpl5 单倍体不足在 Diamond Blackfan 贫血造血干/祖细胞功能中的作用
- 批准号:
10578722 - 财政年份:2022
- 资助金额:
$ 50.03万 - 项目类别: